AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (117)

Latest Posts

About This Stock More About This Stock
November 2018 Stock Purchases
Article By: Dividend Diplomats
Friday, November 30, 2018 6:01 PM EST
After a crazy October that saw wild swings in the market and a lot of small purchases, November was calmer as many companies rebounded from that rough October.
In this article: LEG, XOM, ABBV
Read
Stocks For You To Swing-Trade: ITW, CTXS, ABBV
Article By: Ryan Mallory
Wednesday, November 14, 2018 5:16 AM EST
Take a look at three trading ideas to prep you for the next trading session.
In this article: ITW, CTXS, ABBV
Read
Six Companies Growing Dividends For Shareholders
Article By: Dividend Growth Investor
Monday, November 12, 2018 7:16 AM EST
Over the past week, there were six companies that raised dividends to shareholders.
In this article: EMR, SEP, ABC, ADP, VVC, ABBV
Read
The Income Opportunity With Pipelines
Article By: Financial Velociraptor
Monday, October 15, 2018 12:07 PM EST
This is a discussion of what has changed in the MLP space.
In this article: KMI, ABBV
Read
AbbVie Dividend Stock Analysis
Article By: Dividend Growth Investor
Thursday, September 13, 2018 5:37 PM EST
The annual dividend per share has increased from $1.60/share in 2013 to $2.56/share in 2017. Based on its most recent dividend increase, the company’s forward annual dividend comes out to $3.84/share.
In this article: ABBV
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments